Fresenius Medical Care Asia Pacific Continues to Forge Organization-Wide Inclusion and Diversity
March 08 2021 - 12:56AM
Business Wire
Women’s Leadership Initiative launches on
International Women’s Day
Fresenius Medical Care, the world’s leading provider of products
and services for individuals with renal diseases, has today
launched its Asia Pacific Women’s Leadership Initiative (WLI) as a
catalyst to continue driving inclusion and diversity (I&D)
amongst its 13,000-strong workforce in the region.
Launching on International Women’s Day, the initiative hosted a
region-wide virtual event with all staff encouraged to attend.
Underpinned by one of the key International Women’s Day missions –
to forge inclusive work cultures where women’s careers thrive and
achievements are celebrated – the event highlighted the important
role of inclusive and diverse leadership in both employee
satisfaction and business success. With a keynote address from
Harjit Gill, Chief Executive Officer at Asia Pacific Medical
Technology Association (APACMed), and showcasing the stories of
inspiring women leaders across Fresenius Medical Care, the launch
has provided the momentum to continue building an even more diverse
and inclusive organization for the future.
This initiative is part of the global Inclusion & Diversity
efforts from Fresenius Medical Care. Fresenius Medical Care is
committed to serving all its patients across the globe with the
same level of care and devotion to their health and wellbeing.
Living up to this commitment requires each employee to bring their
best to the workplace, irrespective of who they are or where they
come from. Inclusion & Diversity enables the company to drive
better business outcomes.
It is widely-known that gender diversity in leadership of an
organization contributes to improved business performance.1 Key
findings from the McKinsey Global Institute’s (MGI) Women Matter
report were shared with the audience during the event, noting that
MGI’s research has identified a marked correlation between the
presence of women at senior levels and the organizational
performance of the company, with an average 47 percent increased
return on equity companies with the greatest female
representation.1 In particular, women, through their leadership
behaviors, help to improve companies’ performance by applying more
of three particular leadership behaviors: people development;
expectations and rewards; and role-modelling.
Donna Hua, Vice President of Product Engineering Center Machines
& Digital Solutions at Fresenius Medical Care’s Global Research
and Development department, whose journey featured as one of four
stories at today’s Leader Showcase, paid testimony to women’s
unique leadership style. With a 25-year career in healthcare, Donna
located several years ago from China to Germany to take on her new
role in a traditionally more male-dominated field. “Over the years,
I have learned that women have a superpower in leadership
positions: strong empathy. We build alliances through our
understanding of others and can use this to everyone’s advantage,
forging a more compassionate work environment that helps everyone
to thrive.”
As one of the world’s largest healthcare providers and employer
in its field, Fresenius Medical Care has long known and practiced
the importance of inclusion and diversity – and is committed to do
more. Gender diversity at the senior management level, and in the
company’s main governance bodies, has increased over time, but
representation at these levels still has room to grow. Determined
to continue closing this gap, the company has identified inclusion
and diversity as one of the five pillars of its Global Employee
Sustainability project. Spurred by this global imperative, the WLI
was formed to promote gender parity at all levels within the
company’s Asia Pacific organizations.
The initiative comprises a working group of 14 women leaders
from across the company’s Asia Pacific countries and functions who
will identify ways to further improve women’s leadership
development. The group will have a particular focus on building the
pipeline of female talent and on influencing a culture of inclusion
that ensures all policies and practices within the organization are
inclusive and non-discriminatory.
“An inclusive and diverse working environment is one where every
individual feels supported and free to be themselves. This
accelerates innovation, fosters employee satisfaction, and in turn
drives financial outcomes”, said Harry de Wit, CEO & President
of Fresenius Medical Care Asia Pacific. “Our employees are the
reason for Fresenius Medical Care’s continued success. It is my
responsibility, both as a leader and as a man, to be a champion for
women in our organization and to work together in building an even
more inclusive mindset where everyone feels secure, respected and
unrestricted in the opportunities that lie before them.”
Reference
- McKinsey & Company, 2017. Women Matter: Ten years of
insights on gender diversity. [online] Available from:
https://www.mckinsey.com/featured-insights/gender-equality/women-matter-ten-years-of-insights-on-gender-diversity
ABOUT FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world's leading provider of
products and services for individuals with renal diseases of which
around 3.7 million patients worldwide regularly undergo dialysis
treatment. Through its network of 4,092 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for 346,553 patients
around the globe. Fresenius Medical Care is also the leading
provider of dialysis products such as dialysis machines or
dialyzers. Along with its core business, the Renal Care Continuum,
the company focuses on expanding in complementary areas and in the
field of critical care. Fresenius Medical Care is listed on the
Frankfurt Stock Exchange (FME) and on the New York Stock Exchange
(FMS).
For more information visit the Company’s website at
www.freseniusmedicalcare.asia.
DISCLAIMER
This release contains forward-looking statements that are
subject to various risks and uncertainties. Actual results could
differ materially from those described in these forward-looking
statements due to various factors, including, but not limited to,
changes in business, economic and competitive conditions, legal
changes, regulatory approvals, results of clinical studies, foreign
exchange rate fluctuations, uncertainties in litigation or
investigative proceedings, and the availability of financing. These
and other risks and uncertainties are detailed in Fresenius Medical
Care AG & Co. KGaA's reports filed with the U.S. Securities and
Exchange Commission. Fresenius Medical Care AG & Co. KGaA does
not undertake any responsibility to update the forward-looking
statements in this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210307005073/en/
Media contact Dr. Alexandra Villar Vice President
Corporate Communications and Branding Asia Pacific
Alexandra.Villar@fmc-asia.com Fresenius Medical Care
Northpoint, 100 Miller Street North Sydney, NSW 2060 Australia
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jul 2023 to Jul 2024